Mode
Text Size
Log in / Sign up
N/A N=473 Randomized Treatment

Improving Medication Adherence in the Alabama Black Belt

Diabetes Mellitus · Medication Adherence

Enrolled (actual)
473
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Change in Self Reported Medication Adherence — 0.78; 0.74; 0.53; 0.62 Scores on a scale — p=0.22

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Living Well with Diabetes Program (Behavioral)
Age
Adult, Older Adult · 19+ yrs
Sex
All
Sponsor
Weill Medical College of Cornell University
Primary completion
Jan 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Self Reported Medication Adherence
0.78; 0.74; 0.53; 0.62; -0.25; -0.12 0.22
PRIMARY
Change in Percentage of HbA1c
8.4; 8.3; 8.1; 8.1; -0.37; -0.24
PRIMARY
Change in Blood Pressure
128.5; 129.3; 130.6; 133.6; 2.5; 4.1
PRIMARY
Change in Low-Density Lipoprotein (LDL) Cholesterol
84.6; 80.7; 80.1; 82.2; -4.5; 1.5
SECONDARY
Change in Quality of Life as Assessed With the Short Form 12- Mental Component
42.7; 42.3; 42.0; 42.1; -0.7; -0.2
SECONDARY
Change in Quality of Life as Assessed With the Short Form-12- Physical Component
39.0; 40.1; 40.4; 40.4; 1.4; 0.3
SECONDARY
Change in Medication Use Self-efficacy Score as Measured by SEAMS Scale and the Perceived Diabetes Self-Management Scale, Which is Associated With A1c
31.9; 32.2; 33.9; 33.1; 2.0; 0.9
SECONDARY
Change in Diabetes-Specific Quality of Life
2.6; 2.3; 1.9; 2.0; -0.6; -0.3
SECONDARY
Number of Physician Office Visits 6 Months
SECONDARY
Number of Hospital Stays at 6 Months
SECONDARY
Number of Emergency Visits at 6 Months
SECONDARY
Change in Diabetes Medication Counts
1.4; 1.3; 1.3; 1.3; -0.04; 0.004

Summary

Medication adherence is especially critical in regions like rural Alabama, where residents have among the worst health outcomes in the US. This project was designed in collaboration with our community member partners and builds on a 5-year partnership of community-engaged research on diabetes peer coaching interventions and our experience with peer storytelling. The investigators will test the hypothesis that an intervention designed within the Corbin and Strauss framework can improve adherence and health outcomes compared to usual care.

Eligibility Criteria

Inclusion Criteria

  • adults
  • type 2 diabetes
  • taking medications for diabetes
  • medication non adherent

Exclusion Criteria

  • nursing home residence
  • plans to move away in the next year
  • advanced illnesses such as hemodialysis, cancer or dementia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02274844). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search